関連する実験動画

Updated: May 6, 2026

A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible
10:42

A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible

Published on: January 28, 2020

6.6K

1 つまたは 2 つのインプラントでサポートされる下のオーバーデントゥーの有効性: 一括的なシステマティックレビュー

Gabriela da Silva Lemos, Francisbênia Alves Silvestre, Nicole Escórcio de Meneses

    Journal of the American Dental Association (1939)
    |September 4, 2025
    PubMed
    まとめ

    シングル・インプラント・レテインド・下矯正 (1i-MOs) は,インプラントの喪失と義肢の失敗に短期的な効果を示しています. しかし,長期的な有効性と患者中心的な結果は不確実であり,さらなる研究が必要である.

    キーワード:
    オーバーデンチュア歯科インプラント下義肢

    さらに関連する動画

    Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla05:54

    Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla

    Published on: October 18, 2021

    1.9K
    Effects of Mechanical Methods Used in Peri-implantitis Treatment on Implant Surface Decontamination and Roughness06:36

    Effects of Mechanical Methods Used in Peri-implantitis Treatment on Implant Surface Decontamination and Roughness

    Published on: March 14, 2025

    358

    関連する概念動画

    Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

    Bioavailability Study Design: Single Versus Multiple Dose Studies

    Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
    388
    Bioequivalence of Drugs: Drugs with Multiple Indications01:09

    Bioequivalence of Drugs: Drugs with Multiple Indications

    The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
    230